We are live on ! Find out more
CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

93 hedge funds and large institutions have $132M invested in Cascadian Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

205% more call options, than puts

Call options by funds: $513K | Put options by funds: $168K

27% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 22

0% more funds holding

Funds holding: 93 → 93 (0)

0% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 17

15% less capital invested

Capital invested by funds: $155M → $132M (-$23.5M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
93
Holders Change
–
Holders Change %
0%
% of All Funds
2.44%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
17
Increased
28
Reduced
22
Closed
17
Calls
$513K
Puts
$168K
Net Calls
+$345K
Net Calls Change
-$249K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$7M
2
BFA
BlackRock Fund Advisors
California
+$3.48M
3
AFM
Anson Funds Management
Texas
+$2.37M
4
DS
DRW Securities
Illinois
+$1.47M
5
ARTA
A.R.T. Advisors
New York
+$1.12M

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$3.98M
2
RG
Redmile Group
California
-$3.68M
3
CS
Candriam SCA
Luxembourg
-$2.87M
4
EC
EcoR1 Capital
California
-$2.58M
5
QF
QVT Financial
New York
-$1.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
FO
26
FT Options
Illinois
$666K +$861K +50,002 New
BA
27
BlackRock Advisors
Delaware
$537K -$84.1K -4,883 -11%
Citadel Advisors
28
Citadel Advisors
Florida
$498K +$591K +34,310 +1,122%
NC
29
Nexthera Capital
New York
$444K +$574K +33,333 New
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$434K +$338K +19,623 +151%
Charles Schwab
31
Charles Schwab
California
$394K – – –
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$390K +$8.9K +517 +2%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$371K – – –
TA
34
Teachers Advisors
New York
$344K – – –
Millennium Management
35
Millennium Management
New York
$292K -$76.9K -4,466 -17%
VKH
36
Virtu KCG Holdings
New York
$276K +$285K +16,546 +396%
VEA
37
Virtus ETF Advisers
New York
$275K +$356K +20,654 New
CI
38
Cowen Inc
New York
$254K +$230K +13,333 +234%
OAM
39
Oxford Asset Management
United Kingdom
$230K +$284K +16,496 New
CAM
40
ClariVest Asset Management
California
$226K +$47.6K +2,767 +19%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$218K +$21.4K +1,244 +8%
Connor, Clark & Lunn Investment Management (CC&L)
42
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$211K – – –
ProShare Advisors
43
ProShare Advisors
Maryland
$200K +$259K +15,026 New
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$187K – – –
Stifel Financial
45
Stifel Financial
Missouri
$186K – – –
AQR Capital Management
46
AQR Capital Management
Connecticut
$170K +$113K +6,578 +106%
Morgan Stanley
47
Morgan Stanley
New York
$168K +$155K +9,027 +249%
MLICM
48
Metropolitan Life Insurance Company (MetLife)
New York
$164K – – –
Goldman Sachs
49
Goldman Sachs
New York
$164K +$134K +7,787 +172%
AllianceBernstein
50
AllianceBernstein
Tennessee
$162K – – –
1
2
3 4 5

CASC Hedge Fund Activity: Q4 2015 in Review

93 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Cascadian Therapeutics, Inc. (CASC) for Q4 2015, worth a combined $132M — down 15% from $155M a quarter earlier.

Fund positioning in CASC was balanced in Q4 2015: 17 funds opened new positions, 17 closed out, 28 added to existing stakes and 22 trimmed.

The largest buyer was BVF Inc, adding an estimated $7M. The largest seller was Avoro Capital Advisors, cutting an estimated $3.98M.

  • 93 institutional investors held Cascadian Therapeutics, Inc. (CASC) as of Q4 2015, unchanged from Q3 2015.
  • Funds reported $132M of Cascadian Therapeutics, Inc. stock for Q4 2015, down 15% quarter-over-quarter.
  • 17 funds opened new Cascadian Therapeutics, Inc. positions in Q4 2015 and 17 closed out, a net change of 0 holders.
  • The largest Cascadian Therapeutics, Inc. buyer in Q4 2015 was BVF Inc, an estimated $7M added.
  • The largest Cascadian Therapeutics, Inc. seller in Q4 2015 was Avoro Capital Advisors, an estimated $3.98M sold.

Based on aggregated 13F filings for Q4 2015.